Physician frontline treatment preferences for stage III/IV classic Hodgkin lymphoma: the real-world US CONNECT study.

MLA

Evens, Andrew M., et al. “Physician Frontline Treatment Preferences for Stage III/IV Classic Hodgkin Lymphoma: The Real-World US CONNECT Study.” Future Oncology (London, England), vol. 20, no. 12, Apr. 2024, pp. 749–60. EBSCOhost, https://doi.org/10.2217/fon-2023-0358.

APA

Evens, A. M., Yu, K. S., Liu, N., Surinach, A., Holmes, K., Flores, C., Fanale, M. A., Flora, D. R., & Parsons, S. K. (2024). Physician frontline treatment preferences for stage III/IV classic Hodgkin lymphoma: the real-world US CONNECT study. Future Oncology (London, England), 20(12), 749–760. https://doi.org/10.2217/fon-2023-0358

Chicago

Evens, Andrew M, Kristina S Yu, Nicholas Liu, Andy Surinach, Katherine Holmes, Carlos Flores, Michelle A Fanale, Darcy R Flora, and Susan K Parsons. 2024. “Physician Frontline Treatment Preferences for Stage III/IV Classic Hodgkin Lymphoma: The Real-World US CONNECT Study.” Future Oncology (London, England) 20 (12): 749–60. doi:10.2217/fon-2023-0358.